Researchers at the Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine have published findings that implicate a new chemoprevention gene therapy (CGT) for preventing and treating pancreatic cancer, one of the most lethal and treatment-resistant forms of cancer. Read more.
« VCU School of Pharmacy lends a hand to state’s Council on Aging | Main | Dr. Mary Jo Grap selected for national research award »